Antengene initiates phase II study of ATG-008 in advanced solid tumors with genetic alterations April 12, 2021
Phase III study of casirivimab + imdevimab to prevent symptomatic COVID-19 infection meets endpoints April 12, 2021
Enrollment ongoing in phase I study of tomivosertib plus paclitaxel in advanced breast cancer April 12, 2021
RSS